Nuvation Bio’s headquarters are currently located at 1500 Broadway, Suite 1401, New York, NY 10036. We also have corporate offices at 585 Howard St., 3rd Floor, San Francisco, CA 94105.
KPMG LLP
Nuvation Bio was founded in 2018 and began trading on the NYSE under the symbol “NUVB” on February 11, 2021.
Nuvation Bio's fiscal year end is December 31.
Nuvation Bio's Class A Common Stock trades publicly on the NYSE under the symbol "NUVB".
Currently, Nuvation Bio does not pay any dividends.
Nuvation Bio's transfer agent for its Class A Common Stock is Continental Stock Transfer & Trust Company, 1 State Street—30th Floor, New York, NY 10004, Attn: Mark Zimkind, Email: mzimkind@continentalstock.com
By contacting: Continental Stock Transfer & Trust Company, 1 State Street—30th Floor, New York, NY 10004, Attn: Mark Zimkind, Email: mzimkind@continentalstock.com
No, Nuvation Bio does not have a direct stock purchase plan or any similar program. Shares of Nuvation Bio's Class A Common Stock can be purchased through any registered broker.
IR@nuvationbio.com
Please visit the “SEC Filings” page of our website under the “Investors” tab.
67080N 101
Please subscribe to our email alerts at “Investor Email Alerts” page of our website under the “Investors” tab.